scPharmaceuticals Inc (SCPH)
4.825
+0.26
(+5.58%)
USD |
NASDAQ |
May 16, 16:00
4.83
0.00 (0.00%)
Pre-Market: 20:00
scPharmaceuticals Free Cash Flow: -60.45M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -60.45M |
| December 31, 2023 | -59.28M |
| September 30, 2023 | -55.93M |
| June 30, 2023 | -50.69M |
| March 31, 2023 | -43.72M |
| December 31, 2022 | -34.60M |
| September 30, 2022 | -29.86M |
| June 30, 2022 | -26.82M |
| March 31, 2022 | -25.92M |
| December 31, 2021 | -27.16M |
| September 30, 2021 | -29.24M |
| June 30, 2021 | -28.87M |
| March 31, 2021 | -28.56M |
| Date | Value |
|---|---|
| December 31, 2020 | -27.69M |
| September 30, 2020 | -33.35M |
| June 30, 2020 | -34.12M |
| March 31, 2020 | -32.07M |
| December 31, 2019 | -30.44M |
| September 30, 2019 | -21.37M |
| June 30, 2019 | -21.25M |
| March 31, 2019 | -25.86M |
| December 31, 2018 | -28.81M |
| September 30, 2018 | -29.00M |
| June 30, 2018 | -29.59M |
| March 31, 2018 | -27.21M |
| December 31, 2017 | -22.68M |
Free Cash Flow Range, Past 5 Years
-60.45M
Minimum
Mar 2024
-21.25M
Maximum
Jun 2019
-35.07M
Average
-30.15M
Median
Free Cash Flow Benchmarks
| Anika Therapeutics Inc | -4.142M |
| Spero Therapeutics Inc | -33.00M |
| electroCore Inc | -11.37M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -26.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.70M |
| Cash from Investing (Quarterly) | 29.32M |
| Cash from Financing (Quarterly) | 0.015M |
| Free Cash Flow Per Share (Quarterly) | -0.4544 |
| Free Cash Flow to Equity (Quarterly) | -18.28M |
| Free Cash Flow Yield | -32.29% |